Rafaela Avelino da Costa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rafaela Avelino da Costa has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Abel Vieira de Melo Bisneto
Department of Genetics, Laboratory of Radiobiology and Mutagenesis, Av. Esperança s/n, Campus Samambaia, Federal University of Goiás , Goiânia , Goiás, 74690-900
1 shared publication - Carlos Filipe Camilo-Cotrim
Biotechnology Laboratory, BR-153 3105 Fazenda Barreiro do Meio, State University of Goiás , Anápolis, Goiás, 75132400
1 shared publication - Cátia Lira Do Amaral
Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
1 shared publication - Diego dos Santos Reis
Laboratory of Pharmacology and Toxicology of Natural and Synthetic Products, BR-153 3105 Fazenda Barreiro do Meio, State University of Goiás , Anápolis, Goiás, 75393-365
1 shared publication - Elisa Flávia Luiz Cardoso Bailão
Central Campus, State University of Goiás
1 shared publication - Jamira Dias Rocha
Biotechnology Laboratory, BR-153 3105 Fazenda Barreiro do Meio, State University of Goiás , Anápolis, Goiás, 75132400
1 shared publication
Latest Publications
- 11 July 2026
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 15 (4)
Cytotoxic but not genotoxic: toxicological evaluation of the herbicide mixture S-metolachlor + flumioxazin in human cells, rodents, and bacteria
Flumioxazin and S-metolachlor are widely used in soybean cultivation and frequently co-occur in the environment due to their persistence. This study investigated the cytotoxic, genotoxic, and mutagenic potential of a commercial formulation containing this herbicide mixture using an integrated in vitro and in vivo approach. Cytotoxicity was assessed in human erythrocytes and lymphocytes, while mutagenicity was evaluated using the Ames test with Salmonella typhimurium strains TA98 and TA100, without metabolic activation. In vivo genotoxicity was examined in Wistar rats orally exposed for 28 days, followed by the comet assay in bone marrow. The mixture induced concentration-dependent cytotoxicity, with significant hemolysis (EC50 0.093 mg/mL) and reduced lymphocyte viability (IC50 0.219 mg/mL). In contrast, no genotoxic alterations were detected in bone marrow comet assay parameters (250, 500, and 1,000 mg/kg), and mutagenic activity was not confirmed according to Ames test criteria (0.06 to 18.90 mg/plate). Collectively, these findings indicate that, although the mixture exhibited marked cytotoxicity in human cells, it did not show detectable genotoxic or mutagenic effects under the specific experimental conditions tested. These conclusions should be interpreted within the limitations of the present study, particularly the use of only TA98 and TA100 strains, the absence of metabolic activation in the Ames test, and the evaluation of bone marrow as the only tissue in the in vivo comet assay. The cytotoxic effects observed at field-dose-derived concentrations suggest the importance of further ecotoxicological evaluations, particularly regarding potential risks to non-target organisms with limited detoxification capacity.
- 11 July 2026
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 15 (4)
Cytotoxic but not genotoxic: toxicological evaluation of the herbicide mixture S-metolachlor + flumioxazin in human cells, rodents, and bacteria
Flumioxazin and S-metolachlor are widely used in soybean cultivation and frequently co-occur in the environment due to their persistence. This study investigated the cytotoxic, genotoxic, and mutagenic potential of a commercial formulation containing this herbicide mixture using an integrated in vitro and in vivo approach. Cytotoxicity was assessed in human erythrocytes and lymphocytes, while mutagenicity was evaluated using the Ames test with Salmonella typhimurium strains TA98 and TA100, without metabolic activation. In vivo genotoxicity was examined in Wistar rats orally exposed for 28 days, followed by the comet assay in bone marrow. The mixture induced concentration-dependent cytotoxicity, with significant hemolysis (EC50 0.093 mg/mL) and reduced lymphocyte viability (IC50 0.219 mg/mL). In contrast, no genotoxic alterations were detected in bone marrow comet assay parameters (250, 500, and 1,000 mg/kg), and mutagenic activity was not confirmed according to Ames test criteria (0.06 to 18.90 mg/plate). Collectively, these findings indicate that, although the mixture exhibited marked cytotoxicity in human cells, it did not show detectable genotoxic or mutagenic effects under the specific experimental conditions tested. These conclusions should be interpreted within the limitations of the present study, particularly the use of only TA98 and TA100 strains, the absence of metabolic activation in the Ames test, and the evaluation of bone marrow as the only tissue in the in vivo comet assay. The cytotoxic effects observed at field-dose-derived concentrations suggest the importance of further ecotoxicological evaluations, particularly regarding potential risks to non-target organisms with limited detoxification capacity.